Literature DB >> 16638107

Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics.

Ho-Hsiung Lin1, Wen-Yih Wu, Jia-Horng Kao, Ding-Shin Chen.   

Abstract

BACKGROUND: The purpose of the present paper was to correlate hepatitis B virus (HBV) genotype, e antigen titer, HBV-DNA level and precore/basal core promoter mutations with post-partum e antigen clearance in hepatitis B e antigen (HBeAg)-positive carrier mothers.
METHODS: A total of 40 consecutive HBeAg-positive carrier mothers were studied from January 2002 to January 2003. The blood samples were taken at delivery, 3-4 months and at 1 year after delivery, and the follow-up period was until 1 year after delivery. All sera were assayed for HBeAg, HBV-DNA level, HBV genotype and precore/basal core promoter mutations. The correlation between HBV characteristics and post-partum e antigen clearance was analyzed by Mann-Whitney, Pearson chi2 and multiple logistic regression tests.
RESULTS: The mean age of the 40 HBeAg-positive carrier mothers was 29.9 +/- 5.3 years with a mean parity of 1.4 +/- 0.7. Five of them (group I) had post-partum e antigen clearance, which persisted thereafter, whereas the remaining 35 carrier mothers (group II) had persistent positivity of HBeAg during the follow-up period. The prepartum comparisons of HBV characteristics between groups I and II were comparable in terms of demographics and distributions of HBV genotype and precore/basal core promoter mutations. In contrast, group I carrier mothers had lower HBeAg titer and HBV-DNA level than group II carrier mothers (1:80 vs 1:4000, P = 0.02, and 3.75 x 10(5) vs 3 x 10(8) copies/mL, P = 0.028, respectively).
CONCLUSIONS: Post-partum e antigen clearance in HBeAg-positive carrier mothers is closely associated with prepartum low HBeAg titer or HBV-DNA level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638107     DOI: 10.1111/j.1440-1746.2006.04198.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  16 in total

Review 1.  Chronic hepatitis B virus infection and pregnancy.

Authors:  Manoj Kumar; Tarandeep Singh; Swati Sinha
Journal:  J Clin Exp Hepatol       Date:  2012-09-20

Review 2.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

3.  Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype.

Authors:  Aryn A Price; Dana Tedesco; Mona R Prasad; Kimberly A Workowski; Christopher M Walker; Mehul S Suthar; Jonathan R Honegger; Arash Grakoui
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  A pregnant patient with a positive hepatitis B surface antigen.

Authors:  Arjmand Rasool Mufti; Nancy Reau
Journal:  Frontline Gastroenterol       Date:  2012-08-31

Review 5.  Hepatitis B and C in pregnancy: a review and recommendations for care.

Authors:  J C Dunkelberg; E M F Berkley; K W Thiel; K K Leslie
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

6.  Chronic hepatitis B virus (HBV) infection in pregnancy.

Authors:  Hui-Hui Tan; Hock-Foong Lui; Wan-Cheng Chow
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

Review 7.  Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Authors:  Marc G Ghany; Jordan J Feld; Kyong-Mi Chang; Henry L Y Chan; Anna S F Lok; Kumar Visvanathan; Harry L A Janssen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-10

8.  Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.

Authors:  Christine Y Chang; Natali Aziz; Mugilan Poongkunran; Asad Javaid; Huy N Trinh; Daryl Lau; Mindie H Nguyen
Journal:  Am J Gastroenterol       Date:  2016-07-26       Impact factor: 10.864

Review 9.  Management of chronic hepatitis B in pregnancy.

Authors:  Guo-Rong Han; Chuan-Lu Xu; Wei Zhao; Yong-Feng Yang
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

10.  HCV adaptations to altered CD8+ T-cell immunity during pregnancy.

Authors:  Aryn A Price; Arash Grakoui; Jonathan R Honegger
Journal:  Future Virol       Date:  2014-04-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.